Establishment of genomic RNA reference materials for BCR-ABL1 P210 measurement

Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343–56.

Article  CAS  PubMed  Google Scholar 

Ayatollahi H, Keramati MR, Shirdel A, Kooshyar MM, Raiszadeh M, Shakeri S, et al. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran. Caspian J Intern Med. 2018;9:65–70. https://doi.org/10.22088/cjim.9.1.65.

Article  PubMed  PubMed Central  Google Scholar 

Karow A, Gohring G, Sembill S, Lutterloh F, Neuhaus F, Callies S, et al. The cytogenetic landscape of pediatric chronic myeloid leukemia diagnosed in chronic phase. Cancers (Basel). 2022;14. https://doi.org/10.3390/cancers14071712.

Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290–3. https://doi.org/10.1038/243290a0.

Article  CAS  PubMed  Google Scholar 

Heim D, Ebnöther M, Favre G. Chronic myeloid leukemia - update 2020. Ther Umsch. 2019;76:503–9. https://doi.org/10.1024/0040-5930/a001124.

Article  PubMed  Google Scholar 

Quintas-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009;113:1619–30. https://doi.org/10.1182/blood-2008-03-144790.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375–84.

Article  CAS  PubMed  Google Scholar 

Vinhas R, Cordeiro M, Pedrosa P, Fernandes AR, Baptista PV. Current trends in molecular diagnostics of chronic myeloid leukemia. Leuk Lymphoma. 2017;58:1791–804. https://doi.org/10.1080/10428194.2016.1265116.

Article  CAS  PubMed  Google Scholar 

Jain P, Kantarjian H, Patel KP, Gonzalez GN, Luthra R, Kanagal Shamanna R, et al. Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood. 2016;127:1269–75. https://doi.org/10.1182/blood-2015-10-674242.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baccarani M, Castagnetti F, Gugliotta G, Rosti G, Soverini S, Albeer A, et al. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview. Leukemia. 2019;33:1173–83. https://doi.org/10.1038/s41375-018-0341-4.

Article  CAS  PubMed  Google Scholar 

Yu S, Cui M, He X, Jing R, Wang H. A review of the challenge in measuring and standardizing BCR-ABL1. Clin Chem Lab Med. 2017;55:1465–73. https://doi.org/10.1515/cclm-2016-0927.

Article  CAS  PubMed  Google Scholar 

Zhen C, Wang YL. Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation. J Mol Diagn. 2013;15:556–64. https://doi.org/10.1016/j.jmoldx.2013.05.010.

Article  CAS  PubMed  Google Scholar 

ISO 17511:2003. In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials. Geneva, Switzerland: ISO; 2003.

Fu Y, Zhang R, Wu Q, Zhang J, Bao L, Li J. External quality assessment of p210 BCR-ABL1 transcript quantification by RT-qPCR: Findings and recommendations. Int J Lab Hematol. 2018;41:46–54. https://doi.org/10.1111/ijlh.12919.

Article  PubMed  Google Scholar 

Labourier E, Cross NCP, Radich J, Pane F, Pagnano KB, Müller MC, et al. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale. Clin Chem. 2013;59:938–48. https://doi.org/10.1373/clinchem.2012.196477.

Article  CAS  PubMed  Google Scholar 

White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Lynn Wang Y, et al. Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood. 2010;116:e111–7. https://doi.org/10.1182/blood-2010-06-291641.

Article  CAS  PubMed  Google Scholar 

Zhang J-W, Fu Y, Wu Q-S, Bao L-H, Peng R-X, Zhang R, et al. Standardization of BCR-ABL1 quantification on the international scale in China using locally developed secondary reference panels. Exp Hematol. 2020;81:42-9.e3. https://doi.org/10.1016/j.exphem.2019.12.002.

Article  CAS  PubMed  Google Scholar 

Maier J, Lange T, Cross M, Wildenberger K, Niederwieser D, Franke GN. Optimized digital droplet PCR for BCR-ABL. J Mol Diagn. 2019;21:27–37. https://doi.org/10.1016/j.jmoldx.2018.08.012.

Article  CAS  PubMed  Google Scholar 

Niu C, Wang X, Gao Y, Qiao X, Xie J, Zhang Y, et al. Accurate quantification of SARS-CoV-2 RNA by isotope dilution mass spectrometry and providing a correction of reverse transcription efficiency in droplet digital PCR. Anal Bioanal Chem. 2022;414:6771–7. https://doi.org/10.1007/s00216-022-04238-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burke DG, Griffiths K, Kassir Z, Emslie K. Accurate measurement of DNA methylation that is traceable to the international system of units. Anal Chem. 2009;81:7294–301. https://doi.org/10.1021/ac901116f.

Article  CAS  PubMed  Google Scholar 

Lowenthal MS, Quittman E, Phinney KW. Absolute quantification of RNA or DNA using acid hydrolysis and mass spectrometry. Anal Chem. 2019;91:14569–76. https://doi.org/10.1021/acs.analchem.9b03625.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heiss M, Reichle VF, Kellner S. Observing the fate of tRNA and its modifications by nucleic acid isotope labeling mass spectrometry: NAIL-MS. RNA Biol. 2017;14:1260–8. https://doi.org/10.1080/15476286.2017.1325063.

Article  PubMed  PubMed Central  Google Scholar 

Sarin LP, Kienast SD, Leufken J, Ross RL, Dziergowska A, Debiec K, et al. Nano LC-MS using capillary columns enables accurate quantification of modified ribonucleosides at low femtomol levels. RNA. 2018;24:1403–17. https://doi.org/10.1261/rna.065482.117.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong L, Zang C, Wang J, Li L, Gao Y, Wu L, et al. Lambda genomic DNA quantification using ultrasonic treatment followed by liquid chromatography-isotope dilution mass spectrometry. Anal Bioanal Chem. 2012;402:2079–88. https://doi.org/10.1007/s00216-011-5644-5.

Article  CAS  PubMed  Google Scholar 

Niu C, Dong L, Gao Y, Zhang Y, Wang X, Wang J. Quantitative analysis of RNA by HPLC and evaluation of RT-dPCR for coronavirus RNA quantification. Talanta. 2021;228:122227. https://doi.org/10.1016/j.talanta.2021.122227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

CLSI. EP17-A Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline, Clinical and Laboratory Standards Institute; 2004.

ISO 5725–1:1994, Accuracy (Trueness and Precision) of Measurement Methods and Results – Part 1: General Principles and Definitions, Geneva, Switzerland, ISO; 1994.

ISO 5725–2:1994, Accuracy (Trueness and Precision) of Measurement Methods and Results – Part 2: Basic method for the determination of repeatability and reproducibility of a standard measurement method, Geneva, Switzerland, ISO; 1994.

Weaver S, Dube S, Mir A, Qin J, Sun G, Ramakrishnan R, et al. Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods. 2010;50:271–6. https://doi.org/10.1016/j.ymeth.2010.01.003.

Article  CAS  PubMed  Google Scholar 

Burke D. Title of document. In: Quantitative sars cov 2 certified reference material, SARS-CoV-2 Standard NMIA NA050 to NA055. Report ID: 210329, https://www.industry.gov.au/sites/default/files/2020-12/sars-cov-2_c_of_a_b200921_feb_2021.pdf. Accessed 29 Mar 2021.

ISO 17034. General requirements for the competence of reference material producers, Geneva, Switzerland: ISO; 2016.

ISO GUIDE 35:2017. Reference materials — Guidance for characterization and assessment of homogeneity and stability. Switzerland: ISO; 2017.

Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901–28. https://doi.org/10.1038/sj.leu.2401592.

Article  CAS  PubMed 

Comments (0)

No login
gif